MSOS 股價展望與 ETF 分析 - 配息·管理費·持股·NAV·RSI·MACD | 美股今日
10月27日 7:31 PM ET（韓國 10/28 08:31）
詳細指標表
| Category | US Equities - Factor & Thematic | Expense | 0.78% | Return% 1Y | -15.35% | Total Holdings | 25 | Perf Week | 1.25% | Volume | 4,088,410 |
| Asset Type | Equities (Stocks) | AUM | $740M | Return% 3Y | -16.54% | NAV | $3.99 | Perf Month | -21.71% | Avg Volume | 4.75M |
| ETF Type | US Equities | Dividend TTM | - | Return% 5Y | -32.3% | 52W High | -44.28% | Perf Quarter | 0.75% | Rel Volume | 0.86 |
| Active/Passive | Active | Div Gr. 3/5Y | - | Return% 10Y | - | 52W Low | 36.49% | Perf Half Y | -18.71% | Prev Close | $3.97 |
| IPO | 2020/9/2 | Flows% 1M | -6.4% | Return% SI | -25.7% | RSI (14) | 40.45 | Perf YTD | -14.41% | Price | $4.04 |
| Beta | 1.53 | Flows% 3M | -9.56% | Flows% YTD | -6.63% | Flows% 1Y | 2.19% | Perf Year | -11.98% | Volatility(W/M) | 5.36% 5.02% |
| SMA20 | -3.61% | SMA50 | -13.25% | SMA200 | -9.42% | ATR | 0.22 | ||||
AdvisorShares Pure US Cannabis ETF seeks long-term capital appreciation. The fund is an actively managed ETF that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that derive at least 50% of their net revenue from the marijuana and hemp business in the United States and in derivatives that have economic characteristics similar to such securities. It will concentrate at least 25% of its investments in the pharmaceuticals, biotechnology & life sciences industry group within the health care sector. The fund is non-diversified.
前 10 大持股占 基金的 42%
TRLV TRULIEVE CANNABIS CORP 9.56% 
GLAS GLASS HOUSE BRANDS INC 0.93% 過去一年中， 屬於中等
較一年最高價低 44%。
成交量與平時相當。 相當於平均成交量的86%。
若長期持有 表現不如預期
若 5 年前買入，現在的報酬率為 -85.1%。 同期標普 500 為 +70%。
點擊查看數字
價格 波動非常劇烈
最糟時（2021年2月）下跌了 96%，至今尚未完全恢復。
點擊查看數字
沒有股息
目前還沒有可分配的利潤。
資金小幅流入
最近一年流入了相當於資產 2.2% 的新資金。
點擊查看數字
MSOX AdvisorShares MSOS 2x Daily ETF 42M 
